Frank Karbe - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Aduro Biotech Inc (ADRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aduro Biotech Inc (ADRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aduro Biotech Inc (ADRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Frank Karbe made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .

In summary, during the past 3 months, insiders sold 34,097 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 34,097 shares. During the past 18 months, 34,097 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 34,097 shares.

Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Frank Karbe made no insider transaction in Exelixis Inc (EXEL). Other recent insider transactions involving Exelixis Inc (EXEL) include a net sale of 247,500 shares made by Jeffrey Hessekiel , a net sale of 166,722 shares made by Patrick J. Haley , and a net purchase of 190,000 shares made by David Edward Johnson .

In summary, during the past 3 months, insiders sold 66,225 shares of Exelixis Inc (EXEL) in total and bought 190,000 shares, with a net purchase of 123,775 shares. During the past 18 months, 916,236 shares of Exelixis Inc (EXEL) were sold and 310,409 shares were bought by its insiders, resulting in a net sale of 605,827 shares.

Exelixis Inc (EXEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Frank Karbe made no insider transaction in Chinook Therapeutics Inc (KDNY). Other recent insider transactions involving Chinook Therapeutics Inc (KDNY) include a net sale of 21,804 shares made by Andrew James King , a net sale of 95,785 shares made by Eric Dobmeier , and a net sale of 28,266 shares made by Tom Frohlich .

In summary, during the past 3 months, insiders sold 0 shares of Chinook Therapeutics Inc (KDNY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453,260 shares of Chinook Therapeutics Inc (KDNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453,260 shares.

Chinook Therapeutics Inc (KDNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Frank Karbe made no insider transaction in Myovant Sciences Ltd (MYOV). Other recent insider transactions involving Myovant Sciences Ltd (MYOV) include a net sale of 4,051 shares made by Matthew Lang , a net sale of 3,360 shares made by Ferreira Juan Camilo Arjona , and a net purchase of 51,599,200 shares made by Sumitomo Chemical Co., Ltd. .

In summary, during the past 3 months, insiders sold 0 shares of Myovant Sciences Ltd (MYOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,697 shares of Myovant Sciences Ltd (MYOV) were sold and 51,599,200 shares were bought by its insiders, resulting in a net purchase of 51,579,503 shares.

Myovant Sciences Ltd (MYOV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Frank Karbe made no insider transaction in Phathom Pharmaceuticals Inc (PHAT). Other recent insider transactions involving Phathom Pharmaceuticals Inc (PHAT) include a net sale of 36,061 shares made by Molly Henderson , a net sale of 12,715 shares made by Terrie Curran , and a net purchase of 18,500 shares made by Asit Parikh .

In summary, during the past 3 months, insiders sold 20,286 shares of Phathom Pharmaceuticals Inc (PHAT) in total and bought 0 shares, with a net sale of 20,286 shares. During the past 18 months, 3,765,398 shares of Phathom Pharmaceuticals Inc (PHAT) were sold and 41,419 shares were bought by its insiders, resulting in a net sale of 3,723,979 shares.

Phathom Pharmaceuticals Inc (PHAT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Frank Karbe made 2 insider transaction in Better Therapeutics Inc (BTTX) with a net purchase of 379,429. Other recent insider transactions involving Better Therapeutics Inc (BTTX) include a net purchase of 6,202,742 shares made by David P Perry , a net purchase of 988,055 shares made by Geoffrey M. Parker , and a net purchase of 577,040 shares made by Andrew J. Armanino .

In summary, during the past 3 months, insiders sold 0 shares of Better Therapeutics Inc (BTTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Better Therapeutics Inc (BTTX) were sold and 8,236,919 shares were bought by its insiders, resulting in a net purchase of 8,236,919 shares.

Better Therapeutics Inc (BTTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Mountain Crest Acquisition Corp II (MCADU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mountain Crest Acquisition Corp II (MCADU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mountain Crest Acquisition Corp II (MCADU)'s detailed insider trading history can be found in Insider Trading Tracker table.